Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 546

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 2
Chunk 546
---
48,343  
     - 
  
    Share issuance costs 
     (747) 
     - 
  
    Warrant issuance costs 
     (125) 
     - 
  
    Proceeds from issuance of convertible debt 
     2,779  
     - 
  
    Cancellation of warrants 
     (24,769) 
     - 
  
    Repayment of convertible debt 
     (3,795) 
     - 
  
    Debt issuance costs 
     (113) 
     - 
  
    Net cash provided by financing activities 
     21,396  
     - 
  
    Effect of exchange rate changes on cash and cash equivalents 
     306  
     (140)
  
    Net (decrease)/increase in cash and cash equivalents 
     8,875  
     (16,122)
  
    Cash and cash equivalents at beginning of period 
     5,858  
     22,120 
  
    Cash and cash equivalents at end of period 
     15,039  
     5,858 

    Non-cash investing and financing activities 

    Issuance of ELOC warrants at initial fair value 
     806  
     - 
  
    Issuance of convertible note warrants at initial fair value 
     341  
     - 
  
    Issuance of convertible rights at initial fair value 
     282  
     - 
  
    Issuance of Series A warrants at initial fair value 
     2,843  
     - 
  
    Partial conversion of convertible note 
     100  
     - 
  
    Total 
     4,372  
     - 

The accompanying notes are an integral part of
these consolidated financial statements.

F-6

INCANNEX HEALTHCARE INC.

Notes To Audited Consolidated Financial Statements

June 30, 2025 and 2024

Note 1 – Company Overview 

Incannex Healthcare Inc. (“Incannex”)
is a corporation formed under the laws of the State of Delaware in July 2023. Incannex and its subsidiaries are referred to as “the
Company” unless the text otherwise requires.

The Company’s fiscal year end is June 30.
References to a particular “fiscal year” are to the Company’s fiscal year ended June 30 of that calendar